Abstract：
BACKGROUND: Mixed Arterial and Venous Leg Ulcers (MAVLU) are challenging. Clinical evidence specific to MAVLU management is scarce. We evaluated our recent experience with MAVLU patients and reviewed current data regarding MAVLU epidemiology, aetiology, diagnostic assessment and management options.
METHODS: A prospective leg ulcer database was retrospectively interrogated to determine the prevalence and clinical outcome of MAVLU over 2-year period (2021-2022). The literature was reviewed to determine if optimal treatment strategies.
RESULTS: 307 patients attended the ulcer clinic over a 2-year period. Most were venous leg ulcers (71%), 24% were arterial and 5% were MAVLU. The highest healing rate was in MAVLU (93%), followed by (74%) and (41%), in arterial and venous leg ulcer groups, respectively.
CONCLUSIONS: Evidence-based guidelines for MAVLU remain lacking. Well-developed randomised controlled trials are warranted to guide current clinical practice.
METHODS: A prospective leg ulcer database was retrospectively interrogated to determine the prevalence and clinical outcome of MAVLU over 2-year period (2021-2022). The literature was reviewed to determine if optimal treatment strategies.
RESULTS: 307 patients attended the ulcer clinic over a 2-year period. Most were venous leg ulcers (71%), 24% were arterial and 5% were MAVLU. The highest healing rate was in MAVLU (93%), followed by (74%) and (41%), in arterial and venous leg ulcer groups, respectively.
CONCLUSIONS: Evidence-based guidelines for MAVLU remain lacking. Well-developed randomised controlled trials are warranted to guide current clinical practice.
摘要：
背景：混合动脉和静脉腿溃疡（MAVLU）具有挑战性。MAVLU管理特有的临床证据很少。我们评估了我们最近对MAVLU患者的经验，并回顾了有关MAVLU流行病学的当前数据。病因学，诊断评估和管理选择。
方法：回顾性查询前瞻性腿部溃疡数据库，以确定MAVLU在2年期间（2021-2022年）的患病率和临床结果。回顾了文献，以确定是否最佳的治疗策略。
结果：307名患者参加了为期2年的溃疡门诊。大多数是静脉腿部溃疡（71％），24%为动脉，5%为MAVLU。最高的治愈率是MAVLU（93％），其次是(74%)和(41%)，在动脉和静脉腿部溃疡组中，分别。
结论：仍然缺乏MAVLU的循证指南。完善的随机对照试验有必要指导当前的临床实践。
方法：回顾性查询前瞻性腿部溃疡数据库，以确定MAVLU在2年期间（2021-2022年）的患病率和临床结果。回顾了文献，以确定是否最佳的治疗策略。
结果：307名患者参加了为期2年的溃疡门诊。大多数是静脉腿部溃疡（71％），24%为动脉，5%为MAVLU。最高的治愈率是MAVLU（93％），其次是(74%)和(41%)，在动脉和静脉腿部溃疡组中，分别。
结论：仍然缺乏MAVLU的循证指南。完善的随机对照试验有必要指导当前的临床实践。
